Navigation Links
Reportlinker Adds Triple Analysis: Colorectal Cancer, Lymphoma and Peptides
Date:5/25/2011

titive Benchmarking of Lymphoma Drugs by Compound Strategy (8 Compound Strategies) 597-636

9 Selecting Subindication for Lymphoma Drugs (Five Subindications of Lymphoma) 637-657

10 Pipeline and Portfolio Planning: Competitive Benchmarking of the Lymphoma Drug Pipeline by Investigator (152 Companies) 658-938

11 Disclaimer 939

12 Drug Index 940

13 Company Index 948

Figures: Includes 6 Figures

Tables: Includes 222 Tables

Total Number of Pages: 954

Part III: Peptides

5.1 The Scope of this Report 24

5.2 The Competitive Advantage and Disadvantage of Peptide Drugs 26

6 Consider the Therapeutic Peptide Target for the Highest Therapeutic Outcome and Return on Investment (125 Drug Targets) 29-219

7 Emerging New Products to Established Ones: Drug Target Strategies of Peptides by their Highest Stage of Development in Oncology (103 Drug Target Strategies and 145 Peptide Drugs) 220-246

8 Selecting Cancer Indications for Peptide Drugs (52 Cancer Indications) 247-300

9 Pipeline and Portfolio Planning: Competitive Benchmarking of the Peptide Drug Pipeline in Oncology by Investigator (103 Investigators) 301-586

10 Disclaimer 588

11 Drug Index 589

12 Company Index 593

Figures: Includes 4 Figures

Tables: Includes 192 Tables

Total Number of Pages: 596

To order this report:

Pathology Industry: Triple Analysis: Colorectal Cancer, Lymphoma and Peptides

Pathology Bus
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Reportlinker Adds Triple Analysis: Lymphoma, Pancreatic Cancer and Prostate Cancer
2. Reportlinker Adds Triple Analysis: Lymphoma, Prostate Cancer and Antibodies
3. Reportlinker Adds Triple Analysis: Colorectal Cancer, Lymphoma and Pancreatic Cancer
4. Reportlinker Adds United Arab Emirates Neurology Devices Investment Opportunities, Analysis and Forecasts to 2017
5. Reportlinker Adds Drug Delivery Devices Market Outlook in China to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
6. Reportlinker Adds Drug Delivery Devices Market Outlook in United States to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
7. Reportlinker Adds Pharmaceuticals Industry Report - Top 500 Pharmaceuticals Industry Report (Global)
8. Reportlinker Adds Antibiotic Manufacturers - Top 150 Antibiotic Manufacturers (Global)
9. Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
10. Reportlinker Adds Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis
11. Reportlinker Adds Triple Analysis: Lymphoma, Melanoma and Peptides
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... 2015 Research and Markets ... "Stability Testing of Pharmaceuticals (London, UK - December ... By attending this comprehensive two day seminar delegates will: ... studies that are suitable for global arketing - ... manage stability samples and facilities - Know how ...
(Date:9/4/2015)... and MENLO PARK, Calif. , ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical company ... therapies, today announced its financial results for the fiscal ... of recent Company highlights and expected near-term milestones. ... update conference call and live webcast for investors, analysts ...
(Date:9/3/2015)... Sept. 3, 2015  Cipla, a global pharmaceutical company ... needs of all patients, today announced that its UK ... acquire two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan ... conditions, is valued at $550 million and will be ... transactions is over $200 million for the year ended ...
Breaking Medicine Technology:Stability Testing of Pharmaceuticals: 2 Day Seminar - London, UK - December 2-3, 2015 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 3DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 4DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 5DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 6DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 7DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 8Cipla to acquire 100% of generic businesses in US for $550M 2Cipla to acquire 100% of generic businesses in US for $550M 3Cipla to acquire 100% of generic businesses in US for $550M 4Cipla to acquire 100% of generic businesses in US for $550M 5
... Masimo (NASDAQ: MASI ) ... month,s issue of the peer-reviewed journal, Annals of ... measurements provide an "effective means for screening at-risk populations ... to invasive blood gas analysis.  The prospective diagnostic accuracy ...
... Sanare, LLC, a leading provider of care ... new consumer brand, BrightSky, have become National Strategic ... (Logo: http://photos.prnewswire.com/prnh/20110414/FL83264LOGO) The sponsorship makes Sanare ... Association,s newly diagnosed patient initiative called "Living With ...
Cached Medicine Technology:New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 2New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 3New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 4New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 5New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning 6Sanare and BrightSky Announce National Strategic Partnership with American Diabetes Association 2
(Date:9/4/2015)... ... 2015 , ... The Providence Fertility Center will host a Fertility Cocktail Hour" ... freezing. , Date and Time: October 8, 2015 at Waterman Grille restaurant and lounge, ... event will discuss the basics of female fertility and egg freezing, and offer women ...
(Date:9/4/2015)... ... September 04, 2015 , ... Inmar ... (CHPA) joint meeting of its Product, Quality and Manufacturers, Dietary Supplements and Supply ... constantly evolving in the consumer goods industry, it can be difficult for companies ...
(Date:9/4/2015)... San Francisco, CA (PRWEB) , ... September 04, ... ... Ben Amini, announces that CEREC technology is now available at CitiDent. CEREC is ... milling machinery. In addition to saving time for patients by eliminating the need ...
(Date:9/4/2015)... ... September 04, 2015 , ... Bio-Logic Aqua® Research, a ... announced its only mission and research focus: Water Life Science®. In the current ... water evaporation is becoming dangerously accelerated. As a result of the global fresh ...
(Date:9/4/2015)... ... 2015 , ... ECC announces the site selection and commencement ... with intellectual, developmental and acquired disabilities. The first community, named Luna Azul, will ... homes. In this community, adults will live safely and permanently in homes owned ...
Breaking Medicine News(10 mins):Health News:The Providence Fertility Center to Host Fertility Cocktail Hour on October 8, 2015 at Waterman Grille for Women Who Wish to Learn About Their Fertility and Egg Freezing 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4
... is still experimental, and more research is needed, study ... children with peanut allergies to a carefully administered daily ... the point where some of them appear to have ... the researchers, from Duke University Medical Center and Arkansas ...
... All-In-One Mobility Solutions , ... Blue ... proud to announce the branding of RACO,s Advanced Solutions Group ... area network design, RFID compliance and application software development services ...
... less likely to have exams, even if they have problems, ... with inconsistent health-care coverage, or no health care coverage, are ... have vision problems, according to a new study. , The ... adults who took part in the National Health Interview Survey ...
... Requirements , ... ... Commission for Healthcare Information Technology (CCHIT®) today announced that ... CCHIT Certified® 08 Ambulatory EHR meets the Certification Commission,s ...
... InterMune, Inc. (Nasdaq: ITMN ) today announced ... President of InterMune, will present at the Cowen and ... March 17, 2009 at 3:10 p.m. EDT.To access a ... interested parties may log on to the investor relations ...
... say finding could serve as model for diagnosing chronic ... Mental exhaustion may lead people to believe they are ... , A United Kingdom study found that performing mentally ... hit the wall faster than if they performed the ...
Cached Medicine News:Health News:Exposure to Peanuts May Build Tolerance to Allergy 2Health News:Exposure to Peanuts May Build Tolerance to Allergy 3Health News:RACO Brands Its Advanced Solutions Group 2Health News:Eye Care Checkups Tied to Insurance Status 2Health News:Advanced Data System's MedicsDocAssistant™ EHR Receives 08 CCHIT Certification 2Health News:Advanced Data System's MedicsDocAssistant™ EHR Receives 08 CCHIT Certification 3Health News:Mental Exhaustion Impedes Physical Performance 2
... II is a 5 mm suture anchor that ... screw thread design for maximum pull-out strength in ... to minimize the possibility of locking the second ... vertical laser mark on the distal part of ...
The Duet EnCompass Pelvic Floor Diagnostic System is the only equipment specifically designed to perform urodynamics, anorectal manometry, EMG and pudendal nerve latency studies on a single software ...
... The answer is simple: to provide better care ... of patients with lower urinary tract symptoms (LUTS) ... medicine and, due to increases in reimbursement, it ... out, however, you are sending them to someone ...
... threaded) is a 5.5 mm diameter titanium ... with the cortical bone surface to maximize ... thread design substantially improves pull-out strength compared ... advantageous when poor quality bone is encountered, ...
Medicine Products: